insights_auto
Why is LCTX down ၄.၀၁%?
Dive Deeperchevron_right
LCTX:NYSEAMERICAN
Lineage Cell Therapeutics
၀.၉၅ US$
arrow_downward
-၄.၀၁%(-၀.၀၄၀) 1D
၀.၉၆ US$
arrow_upward
+၀.၀၉% (+၀.၀၀၀၉၀)bedtimeAfter hours
Closed: အောက် ၁၂, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LCTX...
Open
၁.၀၀ US$
High
၁.၀၀ US$
Low
၀.၉၄ US$
Mkt. cap
၂၄.၂၃ ကုဋေ
Avg. vol.
၁.၄၁ သန်း
Volume
၁.၆၉ သန်း
52-wk high
၂.၀၉ US$
52-wk low
၀.၈၈ US$
EPS
-၀.၁၄ US$
Beta
၁.၆၀
Shares outstanding
၂၅.၂၉ ကုဋေ
No. of employees
၇၅
Open
၁.၀၀ US$
High
၁.၀၀ US$
Low
၀.၉၄ US$
Mkt. cap
၂၄.၂၃ ကုဋေ
Avg. vol.
၁.၄၁ သန်း
Volume
၁.၆၉ သန်း
52-wk high
၂.၀၉ US$
52-wk low
၀.၈၈ US$
EPS
-၀.၁၄ US$
Beta
၁.၆၀
Shares outstanding
၂၅.၂၉ ကုဋေ
No. of employees
၇၅
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Transcript: Lineage Cell Therapeutics Q2 2026 Earnings Conference Call
Profile
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
About Lineage Cell Therapeutics